Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Director | $13.4M | -$9.29M | -40.9% | Sep 9, 2024 |
SYRE | Spyre Therapeutics, Inc. | Director | $24.4K | May 14, 2024 | ||
KYMR | Kymera Therapeutics, Inc. | Director | $0 | -$741K | -100% | Aug 26, 2024 |
DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | Jun 28, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|